These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34461430)

  • 1. Six-week oral ketamine treatment for chronic suicidality is associated with increased grey matter volume.
    Gallay CC; Forsyth G; Can AT; Dutton M; Jamieson D; Jensen E; Hermens DF; Bennett MR; Lagopoulos J
    Psychiatry Res Neuroimaging; 2021 Nov; 317():111369. PubMed ID: 34461430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging the neuroplastic effects of ketamine with VBM and the necessity of placebo control.
    Höflich A; Ganger S; Tik M; Hahn A; Kranz GS; Vanicek T; Spies M; Kraus C; Windischberger C; Kasper S; Winkler D; Lanzenberger R
    Neuroimage; 2017 Feb; 147():198-203. PubMed ID: 27986606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain volume in chronic ketamine users - relationship to sub-threshold psychotic symptoms and relevance to schizophrenia.
    Chesters RA; Pepper F; Morgan C; Cooper JD; Howes OD; Vernon AC; Stone JM
    Psychopharmacology (Berl); 2022 Nov; 239(11):3421-3429. PubMed ID: 34228135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
    Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
    J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the neurobiology of suicidality: explicating the role of glutamatergic systems through the lens of ketamine.
    Can AT; Mitchell JS; Dutton M; Bennett M; Hermens DF; Lagopoulos J
    Psychiatry Clin Neurosci; 2023 Oct; 77(10):513-529. PubMed ID: 37329495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis.
    de Bartolomeis A; Sarappa C; Buonaguro EF; Marmo F; Eramo A; Tomasetti C; Iasevoli F
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():1-12. PubMed ID: 23800465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low dose oral ketamine treatment in chronic suicidality: An open-label pilot study.
    Can AT; Hermens DF; Dutton M; Gallay CC; Jensen E; Jones M; Scherman J; Beaudequin DA; Yang C; Schwenn PE; Lagopoulos J
    Transl Psychiatry; 2021 Feb; 11(1):101. PubMed ID: 33542187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit.
    Yao N; Skiteva O; Zhang X; Svenningsson P; Chergui K
    Mol Psychiatry; 2018 Oct; 23(10):2066-2077. PubMed ID: 29158578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hippocampal subfield volumes predict treatment response to oral ketamine in people with suicidality.
    Dutton M; Boyes A; Can AT; Mohamed AZ; Hajishafiee M; Shan ZY; Lagopoulos J; Hermens DF
    J Psychiatr Res; 2024 Jan; 169():192-200. PubMed ID: 38042058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bidirectional Homeostatic Regulation of a Depression-Related Brain State by Gamma-Aminobutyric Acidergic Deficits and Ketamine Treatment.
    Ren Z; Pribiag H; Jefferson SJ; Shorey M; Fuchs T; Stellwagen D; Luscher B
    Biol Psychiatry; 2016 Sep; 80(6):457-468. PubMed ID: 27062563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anorexia nervosa, zinc deficiency and the glutamate system: The ketamine option.
    Hermens DF; Simcock G; Dutton M; Bouças AP; Can AT; Lilley C; Lagopoulos J
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jul; 101():109921. PubMed ID: 32169564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors.
    De Berardis D; Fornaro M; Valchera A; Cavuto M; Perna G; Di Nicola M; Serafini G; Carano A; Pompili M; Vellante F; Orsolini L; Fiengo A; Ventriglio A; Yong-Ku K; Martinotti G; Di Giannantonio M; Tomasetti C
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30249029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation by chronic stress and ketamine of ionotropic AMPA/NMDA and metabotropic glutamate receptors in the rat hippocampus.
    Elhussiny MEA; Carini G; Mingardi J; Tornese P; Sala N; Bono F; Fiorentini C; La Via L; Popoli M; Musazzi L; Barbon A
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110033. PubMed ID: 32640261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased suicide attempts in young depressed patients with abnormal temporal-parietal-limbic gray matter volume.
    Peng H; Wu K; Li J; Qi H; Guo S; Chi M; Wu X; Guo Y; Yang Y; Ning Y
    J Affect Disord; 2014 Aug; 165():69-73. PubMed ID: 24882180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of eEF2 kinase in the rapid antidepressant actions of ketamine.
    Suzuki K; Monteggia LM
    Adv Pharmacol; 2020; 89():79-99. PubMed ID: 32616215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral ketamine reduces the experience of stress in people with chronic suicidality.
    Dutton M; Can AT; Beaudequin D; Jensen E; Jones M; Gallay CC; Schwenn PE; Scherman JK; Yang C; Forsyth G; Lagopoulos J; Hermens DF
    J Affect Disord; 2022 Mar; 300():410-417. PubMed ID: 35016117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectral Changes of EEG Following a 6-Week Low-Dose Oral Ketamine Treatment in Adults With Major Depressive Disorder and Chronic Suicidality.
    Anijärv TE; Can AT; Gallay CC; Forsyth GA; Dutton M; Mitchell JS; Hermens DF; Lagopoulos J
    Int J Neuropsychopharmacol; 2023 Apr; 26(4):259-267. PubMed ID: 36789509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety.
    Ballard ED; Ionescu DF; Vande Voort JL; Niciu MJ; Richards EM; Luckenbaugh DA; Brutsché NE; Ameli R; Furey ML; Zarate CA
    J Psychiatr Res; 2014 Nov; 58():161-6. PubMed ID: 25169854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketamine and suicidal ideation in depression: Jumping the gun?
    Rajkumar R; Fam J; Yeo EY; Dawe GS
    Pharmacol Res; 2015 Sep; 99():23-35. PubMed ID: 25982932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder.
    DiazGranados N; Ibrahim LA; Brutsche NE; Ameli R; Henter ID; Luckenbaugh DA; Machado-Vieira R; Zarate CA
    J Clin Psychiatry; 2010 Dec; 71(12):1605-11. PubMed ID: 20673547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.